These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36604174)

  • 1. Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis.
    Tang Y; Li T; Liu W; He Y; Zhu L; Wang ZL; He Y
    J Neurointerv Surg; 2023 Dec; 15(e3):e369-e374. PubMed ID: 36604174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease.
    Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J
    Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of drug coated balloon angioplasty for intracranial atherosclerotic disease.
    Qiao H; Chang CH; Wang AY; Li S; Yang W; Li G; Cen X; Wang R; Lin H
    J Neurointerv Surg; 2023 Nov; 15(e2):e172-e177. PubMed ID: 36171100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
    Ueda T; Takaishi S; Yoshie T; Usuki N; Tatsuno K; Ohtsubo H; Araga T; Kaga Y; Takada T
    BMC Neurol; 2022 Dec; 22(1):477. PubMed ID: 36510182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review.
    Li G; Qiao H; Lin H; Wang R; Chen F; Li S; Yang W; Yin L; Cen X; Zhang Y; Cheng X; Wang AY
    Clin Neurol Neurosurg; 2022 Feb; 213():107065. PubMed ID: 34991058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque modification and stabilization after drug-coated balloon angioplasty for intracranial atherosclerotic lesions.
    Meng Y; Zhang Y; Chu X; Song Y; Zhao W; Zheng M; Zhang J; Han J
    Eur Radiol; 2023 Feb; 33(2):1112-1120. PubMed ID: 36136108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Coated Balloon Treatment in Symptomatic Intracranial High Grade Stenosis : A Retrospective Study of 33 Patients.
    Remonda L; Diepers M; Berberat J; Kahles T; Anon J; Nedeltchev K; Gruber P
    Clin Neuroradiol; 2021 Mar; 31(1):45-49. PubMed ID: 32691077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leave Nothing Behind: Treatment of Intracranial Atherosclerotic Disease with Drug-Coated Balloon Angioplasty.
    Wang AY; Chang CH; Chen CC; Wu YM; Lin CM; Chen CT; Hsieh PC
    Clin Neuroradiol; 2021 Mar; 31(1):35-44. PubMed ID: 32720067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study.
    Gruber P; Braun C; Kahles T; Hlavica M; Anon J; Diepers M; Nedeltchev K; Berberat J; Remonda L
    J Neurointerv Surg; 2019 Jul; 11(7):719-722. PubMed ID: 30415229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sole angioplasty with tiny balloon for high-risk complex symptomatic intracranial atherosclerotic stenosis].
    Qi P; Wang JJ; Wang LJ; Lu J; Hu S; Yang XM; Chen KP; Wang HF; Wang DM
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):458-463. PubMed ID: 29886671
    [No Abstract]   [Full Text] [Related]  

  • 11. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial.
    Yin Y; Shi Y; Cui T; Li H; Chen J; Zhang L; Yu Z; Li H; Yan Y; Wu K; Jin Q
    Am J Kidney Dis; 2021 Jul; 78(1):19-27.e1. PubMed ID: 33418016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials.
    Liao MT; Chen MK; Hsieh MY; Yeh NL; Chien KL; Lin CC; Wu CC; Chie WC
    PLoS One; 2020; 15(4):e0231463. PubMed ID: 32287283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using drug-coated balloons for symptomatic vertebral artery origin stenosis: A systematic review and meta-Analysis.
    Wu S; Yin Y; Li Z; Li N; Ma W; Zhang L
    J Clin Neurosci; 2023 Jan; 107():98-105. PubMed ID: 36527812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to: Correspondence on 'Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis' by Zhang
    Liu W; Tang Y; Li T; He Y
    J Neurointerv Surg; 2023 Dec; 15(e3):e485. PubMed ID: 37989579
    [No Abstract]   [Full Text] [Related]  

  • 16. Correspondence on "Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis" by Tang
    Zhang J; Zhang X; Han J
    J Neurointerv Surg; 2023 Dec; 15(e3):e484. PubMed ID: 36990688
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta-analysis.
    Zhang Y; Yuan FL; Hu XY; Wang QB; Zou ZW; Li ZG
    Clin Cardiol; 2023 Aug; 46(8):877-885. PubMed ID: 37417371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of drug-coated balloon angioplasty versus standard medical therapy on recurrent stroke and mortality rates among patients with symptomatic intracranial atherosclerotic stenosis: protocol for a systematic review and meta-analysis.
    Sun Y; Luo J; Gong H; Xu R; Zhang X; Yang B; Ma Y; Wang T; Jiao L
    BMJ Open; 2023 Nov; 13(11):e078040. PubMed ID: 38016792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study.
    Jia S; Liu J; Sun G; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.